A randomized assessor-blinded comparison of low-irradiance and conventional-irradiance photodynamic therapy for superficial basal cell carcinoma and Bowen disease

Sally H. Ibbotson (Lead / Corresponding author), James Ferguson, Harry Moseley, Ifor D. W. Samuel, Andrea E. Lesar, Robert S. Dawe

Research output: Contribution to journalLetterpeer-review

Abstract

The inconvenience and pain of hospital-based photodynamic therapy (PDT) is sometimes limiting.1 We developed very low irradiance LEDs for ambulatory PDT. Preliminary studies showed this to be convenient and relatively painless.1-4 Here we evaluate the Ambulight® device (Ambicare Health Ltd) in a randomised controlled assessor-blinded study comparing low irradiance ambulatory PDT (APDT) with conventional PDT (CPDT) for superficial basal cell carcinoma (SBCC) and Bowen’s disease (BD) (lesions ≤2cm).
Original languageEnglish
JournalBritish Journal of Dermatology
Early online date21 Sep 2021
DOIs
Publication statusE-pub ahead of print - 21 Sep 2021

Fingerprint

Dive into the research topics of 'A randomized assessor-blinded comparison of low-irradiance and conventional-irradiance photodynamic therapy for superficial basal cell carcinoma and Bowen disease'. Together they form a unique fingerprint.

Cite this